Okunieff, P., Casey-Sawicki, K., Lockney, N. A., Hoppe, B. A.,
Enderling, H., Pinnix, C., . . . Kachnic, L. (2018). Report from the SWOG
Radiation Oncology Committee: Research Objectives Workshop 2017. Clinical Cancer Research, 10 pages.
doi:10.1158/1078-0432.CCR-17-3202
Kim, S. R., Song, N., Yothers, G., Gavin, P. G., Allegra, C. J.,
Paik, S., & Pogue-Geile, K. L. (2018). Tumour sidedness and intrinsic
subtypes in patients with stage II/III colon cancer: Analysis of NSABP C-07
(NRG Oncology). British Journal of
Cancer, 118(5), 629-633. doi:10.1038/bjc.2017.448
Blum, J. L., Flynn, P. J., Yothers, G., Asmar, L., Geyer, C. E.,
Jacobs, S. A., . . . Wolmark, N. (2017). Anthracyclines in early breast
Cancer: The ABC Trials—USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49
(NRG Oncology). Journal of Clinical
Oncology, 35(23), 2647-2655.
doi:10.1200/JCO.2016.71.4147
Kunitake, H., Russell, M. M., Zheng, P., Yothers, G., Land, S.
R., Petersen, L., . . . Ganz, P. A. (2017). Quality of life and symptoms in
long-term survivors of colorectal cancer: results from NSABP protocol LTS-01.
JOURNAL OF CANCER SURVIVORSHIP, 11(1), 111-118. doi:10.1007/s11764-016-0567-y
Sinicrope, F. A., Shi, Q., Allegra, C. J., Smyrk, T. C.,
Thibodeau, S. N., Goldberg, R. M., . . . Alberts, S. R. (2017). Association
of DNA mismatch repair and mutations in BRAF and KRAS with survival after
recurrence in stage III colon cancers: A secondary analysis of 2 randomized
clinical trials. JAMA Oncology, 3(4), 472-480. doi:10.1001/jamaoncol.2016.5469
Song, N., Pogue-Geile, K. L., Gavin, P. G., Yothers, G., Kim, S.
R., Johnson, N. L., . . . Paik, S. (2016). Clinical outcome from oxaliplatin
treatment in stage II/III colon cancer according to intrinsic subtypes:
Secondary analysis of NSABP C-07/NRG oncology randomized clinical trial. JAMA Oncology, 2(9), 1162-1169. doi:10.1001/jamaoncol.2016.2314
Link to Greg Yothers complete bibliography...